INDIA TO PRODUCE 300 MILLION DOSES OF SPUTNIK V NEXT YEAR

19 Dec 2020

India will produce about 300 million doses of Russia’s Sputnik V Covid vaccine next year. Head of the Russian Direct Investment Fund (RDIF), Kirill Dmitriev, said that the production of Sputnik V has begun in other countries, particularly in India, Korea, Brazil, and China, in an interview with Rossiya 24...

WILL INDIANS OPT FOR THE VACCINE?

16 Dec 2020

New Delhi: In November 2020, a survey carried out by Local Circles, a community social media platform revealed that Indians are likely to be hesitant of a COVID-19 vaccine. In the survey, 59% of all respondents (8,936 total respondents) said they will not rush to get the vaccine even if...

COVID-19 VACCINE: QUESTIONS ON EVERYONE’S MIND

16 Dec 2020

A s of December 2020, worldwide around 57 vaccine trials are underway, with 17 trials in Phase 2 or 3. No vaccine trial has so far successfully completed a Phase 3 trial, although, several vaccines in Phase 3 have been approved for emergency use in various countries. Let us break...

WHAT IS THE PLAN FOR DISTRIBUTING THE CORONAVIRUS VACCINE IN INDIA?

16 Dec 2020

Currently, three vaccines are under regulatory review in India, as announced by the head of the National Expert Group on Vaccine Administration for COVID-19 in early December. Three companies: Pfizer, Serum Institute of India (SII) and Bharat Biotech have applied to the drug regulatory body in India, the Central Drugs...

NEW, MORE INFECTIOUS VARIANT OF COVID-19 FOUND IN UK: REPORT

15 Dec 2020

London: London would soon move into the highest level of Covid-19 restrictions due to concern about spiralling numbers of infections, the health secretary said on Monday. London will move into England’s highest tier of coronavirus restrictions—Tier 3—from on Wednesday, Health Secretary Matt Hancock has said. Parts of Essex and parts...

MAKING DEAD VIRUS KILL LIVE ONES: A CASE FOR INACTIVATED COVID-19 VACCINES

12 Dec 2020

Among the vaccines against Covid-19 likely to become available in India in early 2021, Covaxin is an indigenous vaccine, being developed by Bharat Biotech International Limited (BBIL), Hyderabad, in collaboration with the Indian Council of Medical Research (ICMR), New Delhi. The candidate is an inactivated whole virion vaccine. Most of...

We are at the doorstep of getting a coronavirus vaccine: Dr V.K. Paul

12 Dec 2020

New Delhi: In an exclusive interview with The Daily Guardian, Dr V.K. Paul, Member (Health) at NITI Aayog and the head of the National Expert Group for Vaccine Administration, spoke about the availability of vaccines in India and the Co-Win platform, which has been developed to aid the vaccination drive...

AFTER PFIZER & SII, BHARAT BIOTECH SEEKS EMERGENCY USE NOD FOR COVID VACCINE

08 Dec 2020

New Delhi: Hyderabad-based Bharat Biotech on Monday filed an application with the Drugs Controller General of India (DCGI) for emergency use authorisation of its Covid-19 vaccine—Covaxin. The application was filed before the apex drug regulator on Monday evening, a company source told news agency IANS on the condition of anonymity....